APA

Feng H., Guo Z., Ross L. L., Fraser I., Panebianco D., Jumes P., Fandozzi C., Caro L., Talaty J., Ma J., Mangin E., Huang X., Marshall W. L., Butterton J. R., Iwamoto M. & Yeh W. W. (20200603). Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. : The Journal of antimicrobial chemotherapy.

Chicago

Feng Hwa-Ping, Guo Zifang, Ross Lisa L, Fraser Iain, Panebianco Deborah, Jumes Patricia, Fandozzi Christine, Caro Luzelena, Talaty Jennifer, Ma Joanne, Mangin Eric, Huang Xiaobi, Marshall William L, Butterton Joan R, Iwamoto Marian and Yeh Wendy W. 20200603. Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. : The Journal of antimicrobial chemotherapy.

Harvard

Feng H., Guo Z., Ross L. L., Fraser I., Panebianco D., Jumes P., Fandozzi C., Caro L., Talaty J., Ma J., Mangin E., Huang X., Marshall W. L., Butterton J. R., Iwamoto M. and Yeh W. W. (20200603). Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. : The Journal of antimicrobial chemotherapy.

MLA

Feng Hwa-Ping, Guo Zifang, Ross Lisa L, Fraser Iain, Panebianco Deborah, Jumes Patricia, Fandozzi Christine, Caro Luzelena, Talaty Jennifer, Ma Joanne, Mangin Eric, Huang Xiaobi, Marshall William L, Butterton Joan R, Iwamoto Marian and Yeh Wendy W. Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. : The Journal of antimicrobial chemotherapy. 20200603.